European Pharmaceutical Review

NOVEMBER 9, 2023

Following her presentation on age-related disease at BioFuture 2023, Executive Vice President of Drug Development for MyMD Pharmaceuticals ® , Jenna Brager, shares with EPR why the company’s next-generation tumour necrosis factor (TNF)-alpha inhibitor has potential in inflammatory and autoimmune disorders.

Pharmaceutical Companies 108

Pharmaceutical Companies Pharmaceutical Companies Immunization Process Improvement 108

Impact Pharmaceutical Services

SEPTEMBER 15, 2023

Both processes are evolving to enhance product development and output. Upstream processing advancements encompass fed-batch processes , improved cell culture media, advanced feeding strategies, and tailored bioreactor control.

Documentation 59

Documentation Process Improvement Compounding 59

The FDA Law Blog

NOVEMBER 1, 2022

The workshop included presentations by USP on its available standards for advanced therapies, FDA/CBER on CMC challenges for CART cell therapies, and industry approaches to potency testing during CART development, and using Analytical Quality by Design (AQbD) principles in potency assay development. Release testing alone is not sufficient.

FDA 59

FDA Process Improvement 59

European Pharmaceutical Review

AUGUST 29, 2022

They need to resolve any issues that affect cell performance and quality, whether it is media optimisation or process improvement. Our R&D team is happy to present custom media development and manufacturing options for our clients to consider, to meet these challenges.

Process Improvement 91

Process Improvement 91

European Pharmaceutical Review

DECEMBER 1, 2023

For example, in selecting the best technology, we can obtain and use data-based analytics to design scale of tech transfer, to make scientific, data-based process improvements, and to bring efficiencies in process. Also, we can expect to see the utilisation of digital technologies for predictive modelling.

Dosage 87

Dosage Process Improvement FDA 87

Fuld

JANUARY 21, 2020

We often deploy our Intelligence Benchmarking Survey as a barometer for process improvement opportunities with many of our clients and over the years have found that nearly 60 percent of the organizations we’ve surveyed struggle with demonstrating and managing the perceived value of competitive and market intelligence initiatives. . <Read

Process Improvement 78

Process Improvement Documentation 78

ISPE

SEPTEMBER 11, 2023

This article presents relevant insights on the current regulatory and technical landscape for decentralized manufacturing, with select examples of current applications, and discusses perspectives on evolving and adapting the current regulations to meet future capabilities. Accessed March 2023. drug supply.,”

Health and Personal Care Stores 52

Health and Personal Care Stores Vaccines Packaging Documentation 52